1.31 USD
▲+0.03+2.34%
盘后 1.27 0.00%
2026-09-16
市值
$8.50M
市盈率
—
EPS
-2.35
股息率
—
52 周区间
0.58 – 2.50
成交量
11.98K
Beta
0.98
目标价
—
52W 低 0.5852W 高 2.50
价格走势
公司简介
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed Pharmaceuticals and BayMedica Commercial. The InMed Pharmaceuticals segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its prescription-based products include rare cannabinoids ...